NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,883 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,883 Cr |
| Mar2024 | ₹1,388 Cr |
| Mar2023 | ₹715 Cr |
| Mar2022 | ₹170 Cr |
| Mar2021 | ₹442 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,883 Cr | 35.66 | |
| Mar2024 | ₹1,388 Cr | 94.09 | |
| Mar2023 | ₹715 Cr | 320.76 | |
| Mar2022 | ₹170 Cr | -61.57 | |
| Mar2021 | ₹442 Cr | - | |
Compare Profit After Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,730.4 Cr | 2% | 6.7% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 2% |
6.7% |
-32.1% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses